Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial - Concepedia

Concepedia

Publication | Closed Access

Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial

55

Citations

30

References

2016

Year

Carmen Balañá, R. de las Peñas, Juan Manuel Sepúlveda-Sánchez, Miguel Gil‐Gil, Raquel Luque, Óscar Gallego, Cristina Carrato, Carolina Sanz, Gaspar Reynés, Ana Herrero,

Journal of Neuro-Oncology

Neuro-oncologyGenom 009MedicineNeoadjuvant TreatmentNeurologyHigh-grade GliomasCancer TreatmentAnti-cancer AgentRadiation OncologyOncologyGliomaUnresected Glioblastoma

References

	Year	Citations

Page 1

Page 1